Compare WD & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WD | LMAT |
|---|---|---|
| Founded | 1937 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2010 | 2006 |
| Metric | WD | LMAT |
|---|---|---|
| Price | $48.20 | $107.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $78.33 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 342.0K | 204.5K |
| Earning Date | 05-29-2026 | 05-28-2026 |
| Dividend Yield | ★ 5.38% | 0.94% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | 1.64 | ★ 2.52 |
| Revenue | ★ $1,234,306,000.00 | $249,602,000.00 |
| Revenue This Year | $21.12 | $13.66 |
| Revenue Next Year | $8.04 | $8.97 |
| P/E Ratio | ★ $30.79 | $42.12 |
| Revenue Growth | 8.99 | ★ 13.53 |
| 52 Week Low | $42.12 | $71.42 |
| 52 Week High | $90.00 | $115.33 |
| Indicator | WD | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 32.03 | 69.29 |
| Support Level | $42.12 | $81.51 |
| Resistance Level | $66.25 | $115.33 |
| Average True Range (ATR) | 2.93 | 4.34 |
| MACD | -1.12 | 1.23 |
| Stochastic Oscillator | 26.63 | 72.90 |
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.